StockData
Herbalife Ltd. logo

Herbalife Ltd. (HLF) stock

HLFNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 9/3042% below fair value
$15.57−0.47 (-2.93%)

Close on Nov 19, 2026Market cap $1.63BP/E 10.0Yield –

Earnings

Herbalife's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 17, 2027
Q4 FY2026 · estimated, during market hours
Revenue, Q3 FY2026
$1.35B
+3.8% on a year earlier
adjusted diluted EPS, Q3 FY2026
$0.64
$0.50 a year earlier
Latest guidance
Raised
Nov 2, 2026 · 13 items

Quarterly results

Revenue and earnings per share from each of Herbalife's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Dec 31, 2026Feb 17, 2027Expected–––––
Q3 FY2026ended Sep 30, 2026Nov 2, 2026after the close$1.35B+3.8%$0.55$0.64Release
Q2 FY2026ended Jun 30, 2026Aug 5, 2026during market hours$1.30B0.0%-$0.25$0.51Release
Q1 FY2026ended Mar 31, 2026Apr 14, 2026before the open––––Release
Q4 FY2025ended Dec 31, 2025Feb 18, 2026during market hours$1.30B+8.3%$0.81$0.45Release
Q3 FY2025ended Sep 30, 2025Nov 5, 2025during market hours$1.30B+8.3%$0.42$0.50Release
Q2 FY2025ended Jun 30, 2025Aug 6, 2025during market hours$1.30B0.0%$0.48$0.59Release
Q1 FY2025ended Mar 31, 2025Apr 30, 2025during market hours$1.20B-7.7%$0.49$0.59Release
Q4 FY2024ended Dec 31, 2024Feb 19, 2025during market hours$1.20B0.0%$1.74$0.36Release
Q3 FY2024ended Sep 30, 2024Oct 30, 2024during market hours$1.20B-7.7%$0.46$0.57Release
Q2 FY2024ended Jun 30, 2024Jul 31, 2024during market hours$1.30B0.0%$0.05$0.54Release
Q1 FY2024ended Mar 31, 2024May 1, 2024during market hours$1.30B0.0%$0.24$0.49Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Herbalife's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
Net SalesGAAPQ4 FY2026+0.5% – +4.5%–NewNov 2, 2026
Net Salesnon-GAAPQ4 FY2026+2.5% – +6.5%–NewNov 2, 2026
Adjusted EBITDAnon-GAAPQ4 FY2026$145.00M – $165.00M–NewNov 2, 2026
CapExGAAPQ4 FY2026$13.00M – $23.00M–NewNov 2, 2026
Net SalesGAAPFY2026+4.9% – +5.9%–NewNov 2, 2026
Net Salesnon-GAAPFY2026+5.3% – +6.3%–NewNov 2, 2026
Net SalesGAAPFY2026+2.5% – +5.5%+1% – +6%NarrowedAug 5, 2026
Net Sales - Constant Currencynon-GAAPFY2026+2.5% – +5.5%0% – +5%RaisedAug 5, 2026
Adjusted EBITDAnon-GAAPFY2026$670.00M – $690.00M–NewNov 2, 2026
CapExGAAPFY2026$55.00M – $65.00M–NewNov 2, 2026
Adjusted effective tax ratenon-GAAPFY202635%–NewNov 2, 2026
Adjusted effective tax ratenon-GAAPFY202635%30%RaisedAug 5, 2026
Capitalized and prepaid SaaS implementation costsFY2026$35.00M – $45.00M–NewNov 2, 2026
Capitalized SaaS implementation costsFY2026$35.00M – $55.00M$40.00M – $60.00MLoweredAug 5, 2026
Depreciation and amortization, and amortization of SaaS implementation costsFY2026$135.00M – $145.00M–RaisedNov 2, 2026
Depreciation and amortization, and amortization of SaaS implementation costsFY2026$140.00M – $150.00M$140.00M – $150.00MRaisedAug 5, 2026

Guidance vs results

The last range Herbalife gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
Q3 FY2026Revenue growth+0.5% – +4.5%+3.85%Within range
FY2025Revenue growth-0.3% – +0.7%+2%Σ4QAbove range
Q4 FY2025Revenue growth+1.5% – +5.5%+8.33%Above range
Q3 FY2025Revenue growth+0.5% – +4.5%+8.33%Above range
Q3 FY2024Revenue growth-4.5% – 0%-7.69%Below range
Q2 FY2024Revenue growth0% – +3%0%Within range
Q3 FY2022Adjusted Diluted EPS$0.70 – $0.95$0.91Within range
Q3 FY2022Revenue growth-9% – -3%-7.14%Within range
Q2 FY2022Adjusted Diluted EPS$0.60 – $0.80$0.96Above range
Q1 FY2022Adjusted Diluted EPS (a) (b) (c)$0.80 – $1.00$0.99Within range

Guidance history

Every forecast Herbalife put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 2, 2026CapExFY2026$55.00M – $65.00MNew
Nov 2, 2026CapExQ4 FY2026$13.00M – $23.00MNew
Nov 2, 2026Adjusted EBITDAQ4 FY2026$145.00M – $165.00MNew
Nov 2, 2026Adjusted EBITDAQ4 FY2026$155.00M – $175.00MRaised
Nov 2, 2026Adjusted EBITDAFY2026$670.00M – $690.00MNew
Nov 2, 2026Adjusted EBITDAFY2026$700.00M – $720.00MRaised
Nov 2, 2026Adjusted effective tax rateFY202635%New
Nov 2, 2026Capitalized and prepaid SaaS implementation costsFY2026$35.00M – $45.00MNew
Nov 2, 2026Depreciation and amortization, and amortization of SaaS implementation costsFY2026$135.00M – $145.00MRaised
Nov 2, 2026Net SalesQ4 FY2026+0.5% – +4.5%New
Nov 2, 2026Net SalesQ4 FY2026+2.5% – +6.5%New
Nov 2, 2026Net SalesFY2026+4.9% – +5.9%New
Nov 2, 2026Net SalesFY2026+5.3% – +6.3%New
Aug 5, 2026Adjusted effective tax rateFY202635%Raised
Aug 5, 2026Capitalized SaaS implementation costsFY2026$35.00M – $55.00MLowered
Aug 5, 2026Depreciation and amortization, and amortization of SaaS implementation costsFY2026$140.00M – $150.00MRaised
Aug 5, 2026Net Sales - Constant CurrencyFY2026+2.5% – +5.5%Raised
Aug 5, 2026Net SalesFY2026+2.5% – +5.5%Narrowed
Aug 5, 2026Net SalesQ3 FY2026+0.5% – +4.5%New
Aug 5, 2026Net Sales - Constant CurrencyQ3 FY2026+1.5% – +5.5%New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Herbalife filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Results
  4. News
  5. News
  6. Results
  7. Results
  8. Results
  9. Results
  10. Results
  11. Results
  12. Results
  13. Results
  14. Results
  15. Results

See a number that looks wrong?